BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21447982)

  • 1. Long-term remissions in metastatic malignant melanoma following chemotherapy and tamoxifen maintenance.
    Metzner B; Casper J; Hartung G; Rosien B; Hölzle E; Pelzer P; Köhne CH
    Onkologie; 2011; 34(4):208-9. PubMed ID: 21447982
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness and safety of combined mustoforan, cisplatin and tamoxifen for disseminated cutaneous melanoma (results of the IC4-10036-46-RU trial)].
    Konstantinova MM; Gershanovich ML; Akimov MA; Nosov DA; Bogdanova NV
    Vopr Onkol; 2005; 51(5):550-7. PubMed ID: 16756009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen and chemotherapy for refractory metastatic malignant melanoma.
    McKeage MJ; Lorentzos A; Gore ME
    N Engl J Med; 1993 Jan; 328(2):140-1. PubMed ID: 8416433
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH; Ang PT
    Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma.
    McClay EF; Mastrangelo MJ; Bellet RE; Berd D
    Cancer Treat Rep; 1987 May; 71(5):465-9. PubMed ID: 3567970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy of malignant melanoma].
    Karakousis CP
    Chirurg; 1986 Oct; 57(10):606-11. PubMed ID: 3792110
    [No Abstract]   [Full Text] [Related]  

  • 7. The chemohormonal therapy of metastatic melanoma: possible benefit of tamoxifen.
    Crowell EB; Higa GM
    W V Med J; 1993 Jun; 89(6):233-5. PubMed ID: 8322461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
    McClay EF; McClay ME; Monroe L; Baron PL; Cole DJ; O'Brien PH; Metcalf JS; Maize JC
    Br J Cancer; 2000 Jul; 83(1):16-21. PubMed ID: 10883662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for metastatic malignant melanoma: old drugs and new strategies.
    Mouawad R; Sebert M; Michels J; Bloch J; Spano JP; Khayat D
    Crit Rev Oncol Hematol; 2010 Apr; 74(1):27-39. PubMed ID: 19781957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.
    Durando X; Thivat E; D'Incan M; Sinsard A; Madelmont JC; Chollet P
    BMC Cancer; 2005 Nov; 5():147. PubMed ID: 16287507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic chemotherapy.
    Klimek VM; Wolchok JD; Chapman PB; Houghton AN; Hwu WJ
    Clin Plast Surg; 2000 Jul; 27(3):451-61, ix-x. PubMed ID: 10941565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of malignant melanoma].
    Avril MF
    Ann Dermatol Venereol; 1988; 115(9):959-68. PubMed ID: 2464963
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term results of melphalan-based isolated limb perfusion with or without low-dose TNF for in-transit melanoma metastases.
    Rossi CR; Pasquali S; Mocellin S; Vecchiato A; Campana LG; Pilati P; Zanon A; Nitti D
    Ann Surg Oncol; 2010 Nov; 17(11):3000-7. PubMed ID: 20429035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of metastatic malignant melanoma localized to an extremity].
    Jacobsen KD; Tausjø J; Hager B; Gundersen S
    Tidsskr Nor Laegeforen; 2010 Jan; 130(1):21-4. PubMed ID: 20094118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myocardial infarction induced by cisplatin-based combination chemotherapy for malignant melanoma: a case report.
    Fukunaga T; Soejima H; Sugamura K; Kojima S; Sugiyama S; Sakamoto T; Yoshimura M; Tanoue T; Kageshita T; Ono T; Ogawa H
    J Cardiol; 2006 Apr; 47(4):191-5. PubMed ID: 16637253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
    Cohen SM; Ohnuma T; Ambinder EP; Holland JF
    Cancer Treat Rep; 1986 May; 70(5):688-9. PubMed ID: 2423239
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanoma.
    O'Day SJ; Atkins MB; Boasberg P; Wang HJ; Thompson JA; Anderson CM; Gonzalez R; Lutzky J; Amatruda T; Hersh EM; Weber JS
    J Clin Oncol; 2009 Dec; 27(36):6207-12. PubMed ID: 19917850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.
    Agarwala SS; Ferri W; Gooding W; Kirkwood JM
    Cancer; 1999 May; 85(9):1979-84. PubMed ID: 10223239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.
    Bottoni U; Bonaccorsi P; Devirgiliis V; Panasiti V; Borroni RG; Trasimeni G; Clerico R; Calvieri S
    Jpn J Clin Oncol; 2005 Sep; 35(9):507-13. PubMed ID: 16120623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical complete long-term remission of a patient with metastatic malignant melanoma under therapy with indisulam (E7070).
    Baur M; Gneist M; Owa T; Dittrich C
    Melanoma Res; 2007 Oct; 17(5):329-31. PubMed ID: 17885589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.